Appeal No. 1998-0900 Application No. 08/290,047 The examiner does not offer an explanation as to how claim 1 directed to "Polymerisable enantiomers of optically active dipeptides" should be read as a composition which include mixtures of various optically active compounds. However, our reading of Wagner would suggest that this question is not relevant to the outcome of this aspect of the appeal. Basic to the examiner's position is that one of ordinary skill in this art would recognize the presence of an asymmetric carbon as indicating the existence of optical active isomers of the prior art dipeptides. However, as appellants point out, the disclosed compounds of Wagner, on which the examiner relies (Answer, page 10), do not exhibit asymmetric carbons. Both carbons, which are asymmetric in the claimed compounds, are described as methylene (CH2) by Wagner. (Brief, pages 4-5). Thus, there is nothing about this portion of Wagner which would suggest optically active isomers, and the examiner has provided no evidence which would reasonably suggest the modification of the dipeptides of Wagner in a manner to arrive at the claimed invention. On this record, we find that the examiner has failed to provided evidence which would reasonably established that the claimed subject matter would have been prima facie obvious within the meaning of 35 U.S.C. § 103 at the time of the invention. The examiner's rejection of the claims is fatally defective since it does not properly account for and establish the obviousness of the subject matter as a whole. Where the examiner fails to establish a prima facie case, the rejection is improper and will be 10Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 NextLast modified: November 3, 2007